Karen Watson

Karen Watson has extensive work experience in the pharmaceutical and clinical trial industry. Karen currently holds the position of Senior Director, Business Development, Strategic Accounts at Cytel since August 2020. Prior to that, they worked at Covance as Director of Strategic Accounts from January 2017 to August 2020.

Before joining Covance, Karen was the Director, Sponsor Solutions at Firecrest - ICON's Innovative Site & Patient Platform from January 2016 to January 2017. Karen played a key role in developing innovative clinical trial technologies to improve compliance, consistency, and quality of study-related activities.

Karen's experience also includes working as the International Business Development Director at Worldwide Clinical Trials from November 2013 to December 2015. Prior to that, they owned and operated En Route Sales Solutions from August 2010 to December 2015, where they served as the Owner.

Karen has held various senior positions in other companies including Senior Account Director at i3 Statprobe from May 2007 to August 2010, European Business Development Director at Dendrite International from August 2003 to April 2007, Director of Sales and Marketing at Datatrial Ltd in 2002, European Business Development Director at Dendrite International from January 2001 to April 2002, and Business Development Manager at Quintiles Transnational from June 1998 to January 2001.

Karen Watson's work experience showcases their expertise in business development, strategic accounts, and innovative solutions within the pharmaceutical and clinical trial industry.

Karen Watson attended the University of Cambridge from 1986 to 1990. However, no information is available about the degree program or field of study they pursued during this time.